Sign In
Buy NDAQ
$81.61
-0.88 (-1.07%)
At Close: Jun 24, 2026
Aspire Biopharma Holdings, Inc., Announces Public Listing on Nasdaq
01:10pm, Wednesday, 19'th Feb 2025
NEW YORK CITY, NY / ACCESS Newswire / February 19, 2025 / Aspire Biopharma, Inc. ("Aspire" or the "Company"), a developer of a multi-faceted patent-protected disruptive drug delivery mechanism technol
Sekur Releases Bold 2025 Growth Strategy, Targeting Nasdaq Uplisting and Market Expansion
08:48am, Wednesday, 19'th Feb 2025
MIAMI and TORONTO , Feb. 19, 2025 /PRNewswire/ -- Sekur Private Data Ltd. (OTCQB: SWISF) (CSE: SKUR) (FRA: GDT0) ("Sekur" or the "Company"), a leading Swiss-hosted cybersecurity and privacy communic
eXoZymes Announces Nasdaq Bell Ringing to Commemorate Initial Public Offering
08:25am, Wednesday, 19'th Feb 2025
Monrovia, CA, Feb. 19, 2025 (GLOBE NEWSWIRE) -- eXoZymes, Inc. (Nasdaq: EXOZ) (“eXoZymes”) – a pioneer of AI-engineered enzymes that can transform sustainable feedstock into essential chemicals
Lead Real Estate Co., Ltd Announces Receipt of Nasdaq Delisting Determination
07:30pm, Tuesday, 18'th Feb 2025
TOKYO, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Lead Real Estate Co., Ltd (Nasdaq: LRE) (“LRE” or “the Company”), a Japanese real estate developer of luxury residential properties, including single-f
Nasdaq 100 and S&P 500: Nvidia Extends Gains, US Stocks Eye Record Highs
11:17am, Tuesday, 18'th Feb 2025
S&P 500 nears record highs as Nvidia drives tech stocks. Dow slips with UnitedHealth weighing.
AppTech Payments Corp. Granted Extension for Continued Listing on Nasdaq
08:15am, Tuesday, 18'th Feb 2025
CARLSBAD, Calif., Feb. 18, 2025 (GLOBE NEWSWIRE) -- AppTech Payments Corp. (“AppTech or the “Company”) (NASDAQ: APCX) a pioneering Fintech company powering frictionless commerce, today announced
This Nasdaq 100 Component Has A 5.5% Yield & Sells For Less Than Book
08:02am, Tuesday, 18'th Feb 2025
Kraft Heinz has been named as the ''Top Dividend Stock of the Nasdaq 100'', according to Dividend Channel, which published its most recent ''DividendRank'' report. The report noted that among the comp
Lichen China Limited Announces Receipt of Nasdaq Delisting Notice Subject to Hearing Request
08:00am, Tuesday, 18'th Feb 2025
XIAMEN, China , Feb. 18, 2025 /PRNewswire/ -- Lichen China Limited (Nasdaq: LICN ) ("Lichen China" or the "Company"), a dedicated financial and taxation service provider in China today announced�
The Smartest Nasdaq Exchange-Traded Fund (ETF) to Buy With $2,000 Right Now
12:10pm, Monday, 17'th Feb 2025
The Nasdaq Composite is one of the U.S. stock market's three major indexes, tracking almost every stock on the Nasdaq stock exchange.
GCL & RF Acquisition Corp. Complete Business Combination, GCL Commence Trading on Nasdaq Ticker “GCL” & Announces Bell Ringing to Commemorate Listing
Oncolytics Biotech® Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
05:15pm, Friday, 14'th Feb 2025
SAN DIEGO and CALGARY, AB , Feb. 14, 2025 /PRNewswire/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, today anno
Luokung Announces Receipt of Nasdaq Delisting Notice Subject to Hearing
04:30pm, Friday, 14'th Feb 2025
BEIJING, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Luokung Technology Corp. (NASDAQ: LKCO) (“Luokung” or the “Company”) today announced that on February 11, 2025, it has received a letter (the “Lett
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:15pm, Friday, 14'th Feb 2025
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK; the “Company”), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy, cardio
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:15pm, Friday, 14'th Feb 2025
MIAMI--(BUSINESS WIRE)---- $SMMT--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced the grant of inducement awards of options to purchase a collective total of
Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Friday, 14'th Feb 2025
SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that on February 6, 2025, the Compensation Committee of Acadia's Board of Directors (the “Committee”) granted
